Behnood Bikdeli

@bbikdeli

🩺investigator, #thrombosis,🫀outcomes @BrighamWomens @harvardmed #CORE Editor @NEJMClinician @JACCJournals @ThrombosisRese1, via @YaleIMed @NYPCUCVI 🎹

Boston, MA Joined October 2019

345 Following 1.3K Followers 1.6K Posts

Latest posts 5

Pinned post

Behnood Bikdeli @bbikdeli Sep 27

🧵...
Global 🗺️burden of #Venous #Thromboembolism: Honored to present our multi-year investigation w interim estimates &🔦data desert/ gaps needing attention @SVM_tweets. Annually >1,600,000 new #PE cases & 2,500,000 DVTs occur. Sim pub in @NatRevCardiol: doi.org/10.1038/s41569…

Behnood Bikdeli @bbikdeli 3d

Behnood Bikdeli
@bbikdeli
·
1m
STREAM is screaming:

Inferior and also non-inferior! Been quite some time since I saw this (EVEREST II was in the same category):

ahajournals.org/doi/10.1161/CI…

@hmkyale

@jsross119

@GreggWStone

Sanjay Kaul @kaulcsmc 3d

When a claim of noninferiority hides factual inferiority!

Data do not support statin discontinuation is safe with respect to MACE.
View quoted post on X

Behnood Bikdeli @bbikdeli 3d

Great privilege to talk to @CMichaelGibson about #HIRPO trial Extension Study #thrombosis @AHAMeetings @MGBResearchNews #AHA2026 @GregoryPiazza4

C. Michael Gibson MD Verified account @CMichaelGibson 3d

Dr. Behnood Bikdeli and Dr. C. Michael Gibson discuss the HIPRO extension study: 1-year treatment with low-intensity apixaban 2.5 mg twice daily reduced the overall 2-year risk of VTE recurrence compared with placebo in patients with enduring risk factors, with loss of benefit within the period without active treatment.

Watch video here: clinicaltrialresults.org/wp-content/upl…

View quoted post on X

Behnood Bikdeli @bbikdeli 3d

Lots of #thrombosis content at the #AHA2026 and @MGBResearchNews is well represented. Honored to present the results of the #HIPRO trial Extension study. Then @GregoryPiazza4 presenting on F XI inhibition for catheter-associated #DVT. @SVM_tweets @AHAMeetings

Behnood Bikdeli @bbikdeli 4d

Honored to share the stage with such esteemed faculty at #AHA2026 to talk about grant funding. Thank you @AHAScience @American_Heart for supporting my career with awards that have been invaluable for the science we generate. @MGBResearchNews